Breaking News

FDA approves first cell therapy for solid tumors

February 20, 2024
Metastatic melanoma cells
Julio C. Valencia,/NCI Center for Cancer Research

STAT+ | In 'major milestone,' FDA approves first cell therapy for solid tumors

A tumor infiltrating lymphocyte therapy by Iovance helped a significant number of advanced melanoma patients.

By Angus Chen


STAT+ | Leading MD Anderson oncologist disputes junior scientist's claims in lawsuit over research credit

Padmanee Sharma, one of MD Anderson's most influential researchers, provided her own account of events in a contentious case.

By Angus Chen


'All of Us' reports half of the genomes it has sequenced are from non-Europeans

The data release this week includes the whole genome sequences of nearly 250,000 participants — half of whom are of non-European ancestry.

By Megan Molteni



More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Cancer Briefing? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2024, All Rights Reserved.

No comments